Suvretta Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$60.1M |
| 2 |
Amazon
AMZN
|
+$54.1M |
| 3 |
Yum! Brands
YUM
|
+$51M |
| 4 |
Royalty Pharma
RPRX
|
+$39.8M |
| 5 |
ETNB
89bio
ETNB
|
+$28.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$102M |
| 2 |
Tapestry
TPR
|
+$83M |
| 3 |
Las Vegas Sands
LVS
|
+$78.1M |
| 4 |
Union Pacific
UNP
|
+$56.7M |
| 5 |
AT&T
T
|
+$54.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 48.7% |
| 2 | Consumer Discretionary | 12.85% |
| 3 | Miscellaneous | 12.45% |
| 4 | Technology | 6.69% |
| 5 | Communication Services | 5.61% |
Similar funds
Suvretta Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Suvretta Capital Management held 115 positions worth $2.37B, down 0.57% from $2.38B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Suvretta Capital Management withdrew a net $298M in Q1 2023, closing 20 positions and reducing 14 holdings. Its most notable exit was Otis Worldwide, an estimated $102M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 47% a quarter earlier, followed by Consumer Discretionary and Miscellaneous.
Against the trend, Suvretta Capital Management opened a new position in Amazon worth $57.8M.
- Suvretta Capital Management's largest Q1 2023 buy was Amazon: 559,490 shares worth $57.8M.
- Suvretta Capital Management added most to Elevance Health in Q1 2023, an estimated $60.1M increase.
- Suvretta Capital Management's biggest Q1 2023 reduction was Union Pacific, cutting an estimated $56.7M.
- Suvretta Capital Management fully exited Otis Worldwide in Q1 2023, selling an estimated $102M.
- Suvretta Capital Management's ten largest holdings make up 39% of its $2.37B portfolio in Q1 2023.
- Suvretta Capital Management opened 26 new positions and closed 20 in Q1 2023.
- Suvretta Capital Management's portfolio value fell 0.57% quarter-over-quarter to $2.37B.
Based on Suvretta Capital Management's 13F filing for Q1 2023, filed 15 May 2023.